<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01367106</url>
  </required_header>
  <id_info>
    <org_study_id>P081209</org_study_id>
    <nct_id>NCT01367106</nct_id>
  </id_info>
  <brief_title>Effects of &quot;in UTERO&quot; Exposure to Glucocorticoids</brief_title>
  <acronym>GLUCODEX</acronym>
  <official_title>Study of the Effects in Carbohydrate Metabolism and Renal Function of &quot;in UTERO&quot; Exposure to Glucocorticoids in Adult Offsprings (GLUCODEX)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to show that the fetal exposure to excess of
      glucocorticoids is associated with a deficiency of the function beta insulin in the offspring
      adult.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to show that the fetal exposure to excess of
      glucocorticoids is associated with a deficiency of the function beta insulin in the offspring
      adult 23 subjects of exposed offspring will be compared to 23 controls
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2012</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose Tolerance</measure>
    <time_frame>3 days</time_frame>
    <description>the tolerance will be measured by the area under the curve (AUC) of insulin secretion flow</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flow measurement of insulin secretory response to intravenous glucose</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of the secretion of insulin and glucagon in response to arginine</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>21-hydroxylase; Defect</condition>
  <arm_group>
    <arm_group_label>exposed offspring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Euglycemic hyperinsulinemic clamp</intervention_name>
    <description>Euglycemic hyperinsulinemic clamp will be performed at day 2</description>
    <arm_group_label>exposed offspring</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years Aged

          -  Males

          -  Women of childbearing age with a reliable and effective contraception for over 2
             months

          -  Taking dexamethasone between the 6th and the 24th week of gestation by the mother with
             bloc 21-hydroxylase or normal pregnancy for control subjects

          -  Normal blood pressure and heart rate measured at rest: systolic blood pressure &lt;= 150
             mmHg, diastolic blood pressure &lt;= 90 mmHg, heart rate between 55 and 90 beats/mn.

          -  Normal laboratory tests or not clinically significant abnormality NFS, platelets PT,
             aPTT, fibrin TP, TCA, Serum electrolytes, urea, creatinine Uric acid Triglycerides,
             total cholesterol, HDL cholesterol

          -  Fating bood glucose &lt;= 6.9 mmol/l (exclusion criteria for diabetes from the American
             Diabetes Association) during the OGTT.

          -  Negative blood HCG

          -  Accepting the constraints of the protocol and had signed informed and free consent.

          -  Affiliated to the Social Security.

        Exclusion Criteria:

          -  Affected offspring of 21-hydroxylase enzyme block

          -  Taking dexamethasone until pregnancy term by the mother of the subject

          -  Type 2 diabetes in one of the two parents and/or 1 of the 4 grandparents

          -  Pregnancy, Breastfeeding

          -  Body Mass Index (weight/height2)&gt; 50 kg/m2

          -  Poisoning smoking (&gt;10 cigarettes per day, whatever the duration of intoxication)

          -  Any drug taken apart from minor analgesics (aspirin, paracetamol) for less than 8 days
             at the inclusion and oral contraception

          -  Taking recent (less than 3 months) glucocorticoids either taken orally, by inhalation
             or percutaneously

          -  Current infections or recent infections (&lt;10 days)

          -  Neoplastic disorders (with the exception of carcinoma in situ of the cervix or
             cutaneous epithelioma), haematological, cardiovascular, psychiatric, neurological

          -  Having donated blood or participated in a trial within 2 months preceding their
             inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François GAUTIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professor GAUTIER</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2011</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>offspring of 21-hydroxylase enzyme block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucocorticoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

